Internal Medicine, Medical Oncology · Tuscaloosa, AL
NPI
1215955786
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
809 University Blvd E, Dch Cancer Treatment Center
Tuscaloosa, AL, 35401
Phone (205) 759-7800
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
370 services
Medicare patients, 2024
207
Average age 75
Drug cost, 2024
$5.5M
2,151 prescriptions
Company payments, 2025
$2,205
From 43 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David L Hinton was code 99214 (office e&m - established), 255 times for 136 patients. In total David L Hinton billed 370 services in 5 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 255 | 136 | $59.99 | $15K |
| 99213 Office E&M - Established | Facility | 93 | 82 | $38.89 | $3,617 |
By year: 2022 $49K for 831 services; 2023 $43K for 715 services; 2024 $20K for 370 services.
Medicare prescription drug claims, 2024
In 2024, the drug David L Hinton prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 210 prescriptions and refills. In total David L Hinton wrote 2,151 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 210 | 210 | 61 | $3,870 |
| Anastrozole Generic | 172 | 408 | 47 | $2,954 |
| Gabapentin Generic | 99 | 134 | 28 | $1,011 |
| Ondansetron Hcl Generic | 89 | 89 | 62 | $805 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 83 | 83 | 12 | $2,129 |
| Hydroxyurea Generic | 66 | 109 | 14 | $2,351 |
| Acyclovir Generic | 63 | 87 | Under 11 | $951 |
| Prochlorperazine Maleate Generic | 61 | 61 | 40 | $862 |
| Tamoxifen Citrate Generic | 59 | 127 | 17 | $1,758 |
| Letrozole Generic | 58 | 116 | 17 | $1,172 |
| Xtandi Enzalutamide | 57 | 57 | Under 11 | $714K |
| Oxycodone Hcl Generic | 56 | 56 | 12 | $1,597 |
| Lenalidomide Generic | 42 | 42 | Under 11 | $482K |
| Dexamethasone Generic | 39 | 47 | 13 | $629 |
| Revlimid Lenalidomide | 38 | 38 | Under 11 | $544K |
Brand drugs: - claims; generic drugs: 1,750 claims; opioid claims: 414.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David L Hinton $2,205 ($2,205 in general payments such as food, travel and fees) from 43 companies. The largest payer was Novartis Pharmaceuticals Corporation with $235.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 11 | $235 |
| Merck Sharp & Dohme LLC MRK | 7 | $135 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $127 |
| Abbvie Inc. ABBV | 6 | $126 |
| Pfizer Inc. PFE | 9 | $113 |
| GlaxoSmithKline, LLC. GSK | 5 | $104 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $91.19 |
| Daiichi Sankyo Inc. 4568.T | 4 | $82.66 |
| BeOne Medicines USA, Inc. ONC | 4 | $70.82 |
| Gilead Sciences, Inc. GILD | 3 | $68.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.